好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Association of Functional Outcome in Basilar Artery Occlusion in Relation to Baseline Comorbidities: A Retrospective Review
Cerebrovascular Disease and Interventional Neurology
P4 - Poster Session 4 (5:30 PM-6:30 PM)
3-033

We investigated whether baseline comorbidities & vascular risk factors affect the functional outcome of patients with acute basilar artery occlusion (aBAO).

aBAO is rare and accounts for 1% of all strokes presenting with a wide range of symptoms and carrying high mortality and morbidity, despite recent advances in treatment.

This is a descriptive, retrospective single center database. We reviewed patients presenting with aBAO or with symptomatic high grade stenosis in basilar artery at University of New Mexico Hospital (UNMH) between January 1, 2007 and June 31, 2017. Data was extracted from UNMH Cerner database and collected on secured Redcap™ database. Patients with missing data were excluded. All included patients were dichotomized into two groups based on 1-3 months post-stroke modified Rankin Scale (mRS). Patients with mRS 0-2 were grouped as good outcome and patients with mRS 3-6 as poor outcome.

A total of 66 patients were identified. Only 57 patients were included. Total 15 patients (26.3%) had good outcome (mRS 0-2) and 42 (73.7%) had poor outcome (mRS 3-6). The mean age was 64 and 66 years respectively. Overall aBAO was more common in males (73.3% and 76.2% respectively). The common baseline comorbidities present in both groups were as follows: Hypertension in 60% and 57%, Diabetes in 26.7% and 21.4%, Hypercholesterolemia in 33% in both groups, previous history of ischemic stroke in 6.6% and 23.8%, previous history of TIA in 6.6% and 7.1% respectively. History of smoking was present in 13.3% in good outcome group and in 9.5% in poor outcome group.

Our study did not find any correlation between baseline vascular risk factors and comorbidities with functional outcome in patients with aBAO. Other variables such as the infarct location, site of stenosis/occlusion or baseline neurological presentation need to be explored in a large sample to analyze correlation with functional outcome.

Authors/Disclosures
Piotr Bzdyra, MD
PRESENTER
No disclosure on file
Sajid Suriya, MD Dr. Suriya has nothing to disclose.
Asad Ikram, MD, MBBS Dr. Ikram has nothing to disclose.
Saji Bushnaq, MD (The University of Tennessee) No disclosure on file
Christine Meadows, MD Dr. Meadows has nothing to disclose.
Mudassir Farooqui, MD Dr. Farooqui has nothing to disclose.
Saif A. Bushnaq, MD (Texas Tech University Health Sciences Center) Dr. Bushnaq has nothing to disclose.
Atif Zafar, MD (St. Michael's Hospital (University of Toronto)) Dr. Zafar has nothing to disclose.
Michel T. Torbey, MD, MPH, FAAN (University of Oklahoma) Dr. Torbey has nothing to disclose.